Your browser version may not work well with NCBI's Web applications. More information here...
1: Curr Opin Infect Dis. 2001 Dec;14(6):693-6. Links

Coccidioidomycosis: efficacy of new agents and future prospects.

Deresinski SC.

Department of Medicine, Stanford University, Stanford, California, USA. polishmd@earthlink.net

Recent studies have contributed to our understanding of risk factors for severe and potentially life-threatening infections with Coccidioides immitis, allowing a more rational approach to initiation of antifungal therapy for this infection, as well as determining its intensity and duration. A large randomized trial found that itraconazole and fluconazole had similar efficacies in the treatment of progressive nonmeningeal coccidioidomycosis. An animal model of coccidioidal meningitis suggested potential efficacy of systemically administered liposomal amphotericin B. Investigational agents that have activity against C. immitis include posaconazole, voriconazole, caspofungin, and sordarin derivatives.

PMID: 11964886 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Fluconazole (Diflucan® )

    Fluconazole is used to treat fungal infections, including yeast infections of the vagina, mouth, throat, esophagus (tube leading from the mouth to the stomach), abdomen (area between the chest and waist), lungs, blood, a...

  • Itraconazole (Sporanox® )

    Itraconazole capsules are used to treat fungal infections that begin in the lungsand can spread through the body. Itraconazole capsules are also used to treat fungal infections of the fingernails and/or toenails. Itracon...

  • Voriconazole (Vfend® )

    Voriconazole is used to treat serious fungal infections such as invasive aspergillosis (a fungal infection that begins in the lungs and spreads through the bloodstream to other organs) and esophageal candidiasis (infecti...

  • » See all 4 drug reports ...
  • Source: AHFS Consumer Medication Information